Engineering photodynamics for treatment, priming and imaging

Area of Science:

• Biochemistry
• Oncology
• Photochemistry

Background:

• Photodynamic therapy (PDT) utilizes light-activated photosensitizers to generate reactive oxygen species for tumor treatment.
• PDT's efficacy is limited by light penetration depth in tissues.
• Photodynamic priming (PDP) is an inherent process in PDT that sensitizes the tumor microenvironment to adjuvant therapies.

Purpose of the Study:

• To review the mechanisms and applications of PDT and PDP in cancer treatment.
• To explore strategies for enhancing PDT and PDP efficacy through photosensitizer engineering and cellular models.
• To discuss alternative activation sources and barriers to clinical translation.

Main Methods:

• Review of existing literature on PDT and PDP mechanisms and applications.
• Analysis of photosensitizer molecular engineering for improved properties.
• Examination of engineered cellular models for PDT/PDP optimization.
• Discussion of alternative activation methods and clinical translation challenges.

Main Results:

• PDP enhances PDT by permeabilizing tumor vasculature, overcoming biological barriers, and modulating drug resistance.
• Photosensitizer engineering can improve specificity, pharmacodynamics, and enable image-guided PDT.
• Engineered cellular models aid in optimizing PDT and PDP strategies.
• Alternative activation sources and improved photosensitizers show promise for overcoming PDT limitations.

Conclusions:

• PDT and PDP offer versatile approaches to cancer treatment by leveraging photochemistry and priming effects.
• Optimizing photosensitizers and employing engineered models are crucial for advancing PDT and PDP.
• Addressing clinical translation barriers is essential for the widespread adoption of these therapies.